Menu

PV (Pharmacovigilance) Audit Strategy Planning – A Practical Approach to Design and Implementation

By Visited 1 times , 1 Visits today

Start Date: 2021-03-18
End Date: 2021-03-19
Time: 9:00 am to 5:00 pm

Phone: +1-888-717-2436

Location: virtul Seminar,6201 America Center Drive Suite 240 San Jose, CA 95002, USA

Website

Get Direction View Large Map

Description

The European Medicines Agency’s (EMA) Guideline on good pharmacovigilance practices (GVP), Module IV requires that risk-based audits of the quality system be performed at regular intervals to assure that it complies with the established quality requirements and to determine its effectiveness. It includes audit of the pharmacovigilance system which is covered by the quality system. The GVP Modules are applicable to EU-based companies and any company marketing medicinal products on a global basis. The legally required risk based audit strategy shall cover all PV processes and tasks undertaken by or delegated to other departments, MAH affiliates, and third parties such as distributors, external service providers, partners (the PV Universe). The PV Audit Strategy Plan is used to prepare the PV audit program, i.e. annual PV Audit Schedule.

Registration Information

Click the link for registration or ticketing information:

Registration URL

Organizers

Organized by :  Complianceonline

About the Organizers :

In this two day workshop conference we will review the EMA and FDA requirements regarding Risk Based Audits of the PV system and Quality System. The course will focus on the design of the PV audit strategy, identification of the PV processes and entities subject to PV audit (define the PV audit universe), development of risk assessment methodology, development of procedures/tools to monitor PV processes and activities, and implementation of the PV audit strategy plan. Additionally, we will review methods of quality oversight and management of third parties performing PV activities.